Pour les professionnels de la santé

Comparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older Adults

M. Yang, X. Hu, L. Xie, et al.

J Am Med Dir Assoc. 2018 Jun 13. pii: S1525-8610(18)30229-9. doi: 10.1016/j.jamda.2018.04.012. [Epub ahead of print]

The Mini Sarcopenia Risk Assessment (MSRA), a new sarcopenia screening tool, has 2 versions: MSRA-7 (full version, 7 items) and MSRA-5 (short version, 5 items).

We aimed to compare the diagnostic values of MSRA-7 and MSRA-5 to SARC-F for screening sarcopenia.

SARC-F for sarcopenia screening in community-dwelling older adults: Are 3 items enough?

M. Yang, X. Hu, L. Xie, et al.

Medicine (Baltimore). 2018;97(30):e11726

A 3-item SARC-F (termed SARC-F-3 in our study) was recently suggested as a screening tool for sarcopenia.

The aim of this study was to compare the diagnostic value of SARC-F-3 to SARC-F in community-dwelling older people.

Frailty, Hospitalization, and Mortality in Residential Aged Care

O. Theou, J.K. Sluggett, J.S. Bell, et al.

J Gerontol A Biol Sci Med Sci. 2018;73(8):1090-1096

The purpose of this study was to investigate and compare whether frailty is associated with hospitalization and mortality among residents of aged care services.

The impact of sarcopenia on incident homebound status among community-dwelling older adults: A prospective cohort study

K. Uemura, H. Makizako, S. Lee, et al.

Maturitas. 2018;113:26-31

Sarcopenia had a strong impact on the risk of becoming homebound. Particularly in old-old subjects, sarcopenia and physical inactivity may impair people's ability to engage in activities outside the home much more than either their mental status or their level of social participation.

Persistent pain is a risk factor for frailty: a systematic review and meta-analysis from prospective longitudinal studies

M.D. Saraiva, G.S. Suzuki, S.M. Lin, et al.

Age Ageing. 2018 Jul 21. doi: 10.1093/ageing/afy104. [Epub ahead of print]

Pain is prevalent in frail older adults; however, the association of pain and frailty has not been evaluated yet by a systematic assessment of prospective longitudinal studies.

We aimed to assess the association of persistent pain as a risk factor for frailty incidence, using data from longitudinal studies in a systematic review and meta-analysis.

Cholecalciferol or 25-Hydroxycholecalciferol Supplementation Does Not Affect Muscle Strength and Physical Performance in Prefrail and Frail Older Adults

A.M.M. Vaes, M. Tieland, N. Toussaint, et al.

J Nutr. 2018;148(5):712-720

Vitamin D supplementation is proposed as a potential treatment strategy to counteract functional decline in older adults. However, data from randomized trials are either limited or inconsistent.

This study investigated the effect of daily supplementation with 25-hydroxycholecalciferol [25(OH)D3] or cholecalciferol (vitamin D3) on muscle strength and physical performance in older adults.

Pages